Olivier Benvéniste

Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors

Sylvie Boutin, Virginie Monteilhet, P. Véron et al. · Human Gene Therapy · 2010 · 947 citations

Life Sciences, Immunology, Molecular Biology +15

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux et al. · JAMA Internal Medicine · 2020 · 777 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

224th ENMC International Workshop:

Yves Allenbach, Andrew L. Mammen, Olivier Benvéniste et al. · Neuromuscular Disorders · 2017 · 554 citations · Full text

Computing, Mechanical Engineering, Global Navigation Satellite Systems +1

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

K. Mariampillai, Benjamin Granger, Damien Amelin et al. · JAMA Neurology · 2018 · 437 citations · Full text

Medicine, Immunology, Internal Medicine +15

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

Mehdi Touat, Thierry Maisonobe, Omar Ben Hadj Salem et al. · Neurology · 2018 · 330 citations

Life Sciences, Immunology, Pathology +17